Alternatives to Sable Bio
Sable Bio is a Biotechnology tool: AI drug safety startup. Here are the 58 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Sable Bio
Moderna2.0 out of 5 (1)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Anagram TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Gossamer BioNot ratedA biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.
Verdiva BioNot ratedClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
Celea TherapeuticsNot ratedAdvancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).
Terremoto BiosciencesNot ratedDeveloping highly targeted, small molecule medicines.
Showing the next 20 closest matches. See the rest on the Sable Bio profile.
Sponsored rows are paid and labelled. Advertise on this page

